Checchi Capital Advisers LLC Buys 5,123 Shares of UnitedHealth Group Incorporated $UNH

Checchi Capital Advisers LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 29.0% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 22,816 shares of the healthcare conglomerate’s stock after acquiring an additional 5,123 shares during the period. Checchi Capital Advisers LLC’s holdings in UnitedHealth Group were worth $7,118,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently made changes to their positions in UNH. Brighton Jones LLC grew its holdings in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after acquiring an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC grew its position in shares of UnitedHealth Group by 137.1% in the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock valued at $2,033,000 after buying an additional 2,324 shares during the last quarter. Vest Financial LLC grew its position in shares of UnitedHealth Group by 73.5% in the 1st quarter. Vest Financial LLC now owns 12,219 shares of the healthcare conglomerate’s stock valued at $6,400,000 after buying an additional 5,176 shares during the last quarter. Curat Global LLC bought a new stake in UnitedHealth Group in the first quarter valued at approximately $168,000. Finally, Eagle Rock Investment Company LLC boosted its holdings in UnitedHealth Group by 0.9% in the first quarter. Eagle Rock Investment Company LLC now owns 13,565 shares of the healthcare conglomerate’s stock valued at $7,105,000 after acquiring an additional 120 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

UnitedHealth Group Stock Up 1.8%

UnitedHealth Group stock opened at $360.17 on Friday. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The firm has a market capitalization of $326.20 billion, a price-to-earnings ratio of 15.61, a price-to-earnings-growth ratio of 2.34 and a beta of 0.47. The firm’s fifty day moving average price is $307.84 and its two-hundred day moving average price is $354.55. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same period in the previous year, the business posted $6.80 EPS. UnitedHealth Group’s revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio (DPR) is 38.30%.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on UNH shares. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $440.00 price objective on shares of UnitedHealth Group in a research note on Tuesday, August 26th. KeyCorp cut their target price on UnitedHealth Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 30th. Weiss Ratings restated a “sell (d+)” rating on shares of UnitedHealth Group in a report on Saturday, September 27th. Oppenheimer cut their target price on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a research note on Wednesday, July 30th. Finally, UBS Group reissued a “buy” rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Sixteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $358.95.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.